Concepedia

B. Chul Cho

BC

Statistics

Publications

2

Citations

111

H-Index

2

Active since

2018

Affiliations

The Netherlands Cancer Institute(Current)

Yonsei University

B. Chul Cho is an author at The Netherlands Cancer Institute specializing in cancer therapeutics, radiation oncology, and medicine.

Top concepts

Publications per year

2018–2018

2

Publications

2

Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC

Naiyer A. Rizvi, B. Chul Cho, Niels Reinmuth et al. · Annals of Oncology · 2018 · 92 citations · Full text

, , +14

Long-term survival in patients (pts) with advanced NSCLC in the KEYNOTE-010 study overall and in pts who completed two years of pembrolizumab (pembro)

Roy S. Herbst, Edward B. Garon, D.-W. Kim et al. · Annals of Oncology · 2018 · 19 citations · Full text

, , +7

1–2 of 2